OSCR
Oscar Health, Inc.
OSCR has the edge over OSUR overall, supported by stronger fundamentals and stronger modeled upside.
OSUR
OraSure Technologies, Inc.
OSUR has lower modeled downside risk, despite its lower overall score.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
OSUR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Strong |
OSUR's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
OSUR PE Valuation
OSUR has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
OSUR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect OSUR's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over OSUR on earnings quality, reporting a profit while its opponent remains loss making.
OSUR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.70 | +$0.10 |
| Q2 2026 | -$0.70 | -$0.03 |
| Q1 2026 | -$1.05 | -$0.63 |
| Q4 2025 | -$0.94 | -$0.68 |
| Q3 2025 | -$0.80 | -633% |
| Q2 2025 | -$0.67 | -286% |
| Q1 2025 | -$0.42 | -240% |
| Q4 2024 | -$0.26 | -136% |
OSUR lost $0.70 per share over the past year, a smaller loss than the year before.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over OSUR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over OSUR on profitability, with a higher operating margin.
OSUR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30.9M | +14% |
| Q2 2026 | $30.6M | -1.9% |
| Q1 2026 | $27.9M | -6.7% |
| Q4 2025 | $26.8M | -29% |
| Q3 2025 | $27.1M | -32% |
| Q2 2025 | $31.2M | -43% |
| Q1 2025 | $29.9M | -45% |
| Q4 2024 | $37.4M | -51% |
OSUR's revenue is recovering but still below its 2023 peak: $31M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -42% | +18 points |
| Q2 2026 | 18% | +76 points |
| Q1 2026 | -83% | -24 points |
| Q4 2025 | -75% | -42 points |
| Q3 2025 | -59% | -44 points |
| Q2 2025 | -58% | -53 points |
| Q1 2025 | -59% | -46 points |
| Q4 2024 | -33% | -38 points |
OSUR's operating margin was −42% last quarter, up 17 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over OSUR on cash generation, producing positive trailing cash flow while its opponent burns cash.
OSUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$12.5M | -$1.6M |
| Q2 2026 | -$12.3M | -$190K |
| Q1 2026 | -$14.8M | +$5.3M |
| Q4 2025 | -$9.9M | -$9.6M |
| Q3 2025 | -$11M | -188% |
| Q2 2025 | -$12.2M | -295% |
| Q1 2025 | -$20.2M | -491% |
| Q4 2024 | -$347K | -101% |
OSUR has burned cash in most quarters: −$50M over the past year, against −$44M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
OSUR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -1.2M shares |
| 1 year | -5.5% | -4M shares |
| 3 years | -7.2% | -5.3M shares |
| 5 years | -4.2% | -3M shares |
| Available history | +11% | +6.8M shares |
OSUR has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2M |
| Q1 2026 | $5M |
| Q4 2025 | $5M |
| Q3 2025 | $5M |
| Q2 2025 | $4.1M |
| Q1 2025 | $941,000 |
| Q4 2024 | $15,000 |
OSUR spent $12M buying back its own shares over the past year, up 20% from the year before.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
OSUR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -27,857.1x | Net Cash |
| Q2 2024 | -15.0x | Net Cash |
| Q1 2024 | -11.6x | Net Cash |
| Q4 2023 | -5.4x | Net Cash |
| Q3 2023 | -3.4x | Net Cash |
| Q2 2023 | -3.4x | Net Cash |
| Q1 2023 | -2.8x | Net Cash |
| Q4 2021 | -78.2x | Net Cash |
OSUR has more cash than debt.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
OSUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 42.0 | Neutral |
OSUR's weekly RSI is 49 (neutral) and its Stochastic is 42 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
OSUR PE vs Healthcare Sector
| Metric | OSUR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
OSUR has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over OSUR on trend strength, trading above more of its moving averages.
OSUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.82 | 5.2% below |
| 20 week MA | $3.84 | 5.7% below |
| 50 week MA | $3.38 | 7.1% above |
| 100 week MA | $3.26 | 11% above |
| 200 week MA | $4.43 | 18% below |
OSUR's trend is mixed: it's above two of its five weekly moving averages, and 18% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over OSUR on returns for 2026, with the stronger performance.
OSUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.92 | $11.6 | +46% |
| 2021 | $11.6 | $9.25 | -20% |
| 2022 | $9.25 | $4.73 | -49% |
| 2023 | $4.73 | $8.20 | +73% |
| 2024 | $8.20 | $3.62 | -56% |
| 2025 | $3.62 | $2.42 | -33% |
| 2026 YTD | $2.42 | $3.62 | +50% |
OSUR is up 50% so far in 2026, after finishing lower in four of the previous six years.